[Chronic lymphatic leukemia and hairy cell leukemia. Diagnosis and therapy]

Chronic Lymphocytic Leukemia (B-CLL) and Immunocytoma (LP-IC): Clinical and Prognostic Relevance of this Distinction.

Leukemia & lymphoma·2016

Minichromosome maintenance protein 6, a proliferation marker superior to Ki-67 and independent predictor of survival in patients with mantle cell lymphoma.

British journal of cancer·2005

Topoisomerase IIalpha expression in mantle cell lymphoma: a marker of cell proliferation and a prognostic factor for clinical outcome.

Leukemia·2004

Transcription of AML1 in hematopoietic subfractions of normal adults.

Annals of hematology·2002

Leukemia- and lymphoma-associated genetic aberrations in healthy individuals.

Annals of hematology·2002

Monoclonal antibody therapy with CAMPATH-1H in patients with relapsed high- and low-grade non-Hodgkin's lymphomas: a multicenter phase I/II study.

Annals of hematology·2002

[75-year old female with progressive idiopathic lung fibrosis].

Medizinische Klinik (Munich, Germany : 1983)·2011

[Mesenterial lymphangiolipoma - a rare finding in an asymptomatic patient].

Medizinische Klinik (Munich, Germany : 1983)·2011

[Resistant hypertension despite nine different antihypertensive drugs?].

Medizinische Klinik (Munich, Germany : 1983)·2011

[From the design of use study to the assessment of the benefit: with or without pharmaceutical industry?].

Medizinische Klinik (Munich, Germany : 1983)·2011

[Memorandum III "methods for health services research", Part 1 [authors: H. Pfaff, G. Glaeske, E. A. M. Neugebauer, M. Schrappe] and Part 2 [authors: E. A. M. Neugebauer, A. Icks, M. Schrappe] of the Deutsches Netzwerk Versorgungsforschung e.V.: A summary].

Medizinische Klinik (Munich, Germany : 1983)·2011

[Pulmonary affection in advanced liver disease - hepatepulonary syndrome and portopulmonary hypertension].

Medizinische Klinik (Munich, Germany : 1983)·2011

S100 Calcium-Binding Protein 16 (S100A16) Promotes Hepatic Stellate Cell Activation Via Erb-B2 Receptor Tyrosine Kinase 2 (ERBB2)-mediated Glycolysis to Facilitate Liver Fibrosis.

Cell biochemistry and function·2026

Loss of LRRK2 Protects Against Ox-LDL-Induced Endothelial Oxidative Damage Via NRF2.

Molecular and cellular biology·2026

A Rare t(1;11)(q42;q23) Rearrangement with Trisomy 8 and Trisomy 21 in a Pediatric Acute Myeloid Leukemia Patient with Aberrant CD7 Expression and Jacob Syndrome: Diagnostic Value of Conventional Cytogenetics and Fluorescence in Situ Hybridization in a Rapidly Fatal Case.

Journal of the Association of Genetic Technologists·2026

Targeting Compensatory AKT Activation Overcomes Resistance to AXL Inhibition in Acute Lymphoblastic Leukemia.

Molecular cancer therapeutics·2026

Constructing an External Control Arm Using the French REALYSA Cohort to Replicate Outcomes of a Randomized Trial Arm in Advanced Hodgkin Lymphoma.

Clinical pharmacology and therapeutics·2026

Dynamic risk stratification using early CAR-T expansion in R/R LBCL treated with axicabtagene ciloleucel.

British journal of haematology·2026

Related Experiment Videos

[Chronic lymphatic leukemia and hairy cell leukemia. Diagnosis and therapy]

Related Concept Videos

Chronic Lymphocytic Leukemia (B-CLL) and Immunocytoma (LP-IC): Clinical and Prognostic Relevance of this Distinction.

Minichromosome maintenance protein 6, a proliferation marker superior to Ki-67 and independent predictor of survival in patients with mantle cell lymphoma.

Topoisomerase IIalpha expression in mantle cell lymphoma: a marker of cell proliferation and a prognostic factor for clinical outcome.

Transcription of AML1 in hematopoietic subfractions of normal adults.

Leukemia- and lymphoma-associated genetic aberrations in healthy individuals.

Monoclonal antibody therapy with CAMPATH-1H in patients with relapsed high- and low-grade non-Hodgkin's lymphomas: a multicenter phase I/II study.

[75-year old female with progressive idiopathic lung fibrosis].

[Mesenterial lymphangiolipoma - a rare finding in an asymptomatic patient].

[Resistant hypertension despite nine different antihypertensive drugs?].

[From the design of use study to the assessment of the benefit: with or without pharmaceutical industry?].

[Memorandum III "methods for health services research", Part 1 [authors: H. Pfaff, G. Glaeske, E. A. M. Neugebauer, M. Schrappe] and Part 2 [authors: E. A. M. Neugebauer, A. Icks, M. Schrappe] of the Deutsches Netzwerk Versorgungsforschung e.V.: A summary].

[Pulmonary affection in advanced liver disease - hepatepulonary syndrome and portopulmonary hypertension].

S100 Calcium-Binding Protein 16 (S100A16) Promotes Hepatic Stellate Cell Activation Via Erb-B2 Receptor Tyrosine Kinase 2 (ERBB2)-mediated Glycolysis to Facilitate Liver Fibrosis.

Loss of LRRK2 Protects Against Ox-LDL-Induced Endothelial Oxidative Damage Via NRF2.

A Rare t(1;11)(q42;q23) Rearrangement with Trisomy 8 and Trisomy 21 in a Pediatric Acute Myeloid Leukemia Patient with Aberrant CD7 Expression and Jacob Syndrome: Diagnostic Value of Conventional Cytogenetics and Fluorescence in Situ Hybridization in a Rapidly Fatal Case.

Targeting Compensatory AKT Activation Overcomes Resistance to AXL Inhibition in Acute Lymphoblastic Leukemia.

Constructing an External Control Arm Using the French REALYSA Cohort to Replicate Outcomes of a Randomized Trial Arm in Advanced Hodgkin Lymphoma.

Dynamic risk stratification using early CAR-T expansion in R/R LBCL treated with axicabtagene ciloleucel.

Related Experiment Videos

[Chronic lymphatic leukemia and hairy cell leukemia. Diagnosis and therapy]

Related Concept Videos

Related Articles